Edgar Engleman

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
3 years
Director since
2023

3 years of board service in total across 1 board, counting each seat separately. Longest: Bolt Biotherapeutics Inc., 3 years.

3 years · Since 2023

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Nov 30, 2023 Bolt Biotherapeutics Inc. Open-market sale −108,145 $0.86 $93,005
Nov 30, 2023 Bolt Biotherapeutics Inc. Open-market sale −14,934 $0.86 $12,843
Nov 29, 2023 Bolt Biotherapeutics Inc. Open-market sale −22,674 $0.91 $20,633
Nov 29, 2023 Bolt Biotherapeutics Inc. Open-market sale −3,131 $0.91 $2,849
Nov 21, 2023 Bolt Biotherapeutics Inc. Open-market sale −1,707 $0.90 $1,536
Nov 21, 2023 Bolt Biotherapeutics Inc. Open-market sale −236 $0.90 $212
Nov 20, 2023 Bolt Biotherapeutics Inc. Open-market sale −27,465 $0.92 $25,268
Nov 20, 2023 Bolt Biotherapeutics Inc. Open-market sale −3,792 $0.92 $3,489
Nov 17, 2023 Bolt Biotherapeutics Inc. Open-market sale −8,211 $0.93 $7,636
Nov 17, 2023 Bolt Biotherapeutics Inc. Open-market sale −1,134 $0.93 $1,055
Nov 16, 2023 Bolt Biotherapeutics Inc. Open-market sale −7,531 $0.96 $7,230
Nov 16, 2023 Bolt Biotherapeutics Inc. Open-market sale −1,040 $0.96 $998

Questions about Edgar Engleman

What boards is Edgar Engleman on?

Edgar Engleman sits on the board of Bolt Biotherapeutics Inc.

How long has Edgar Engleman served on boards?

Our records show at least 3 years of board service across 1 board, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.